Our portfolio
MVI is accelerating the development of malaria vaccines by testing multiple candidates simultaneously. We are strategically using our resources to support and advance a range of vaccine approaches that target both humoral and cellular immunity.
Find out more about feasibility studies, translational projects, and vaccine candidates by clicking on the respective links. Find out more about the phases of clinical trials.
